|| Print ||
|Archives - April 2008|
|Tuesday, April 01, 2008|
Tiny, stainless steel lattice tubes have been propping coronary arteries open since the 1980s, but never without triggering reactions in some patients that are worse than untreated heart disease. In 2001, scientists began coating stents with drugs to help prevent heart attack-inducing blood clots. But 30,000 out of the 6 million patients worldwide who receive them still die. “Metal is inherently not biocompatible,” says Dr. Kenton Gregory, director of Oregon Medical Laser Center at Providence St. Vincent Medical Center in Portland. More than a decade ago, Gregory decided he needed to go back to nature if stent technology was to move forward. Gregory, whose work at the center has received 22 patents and $25 million in grants, developed a coating modeled after the artery wall’s own lining: a protein called elastin. As the name suggests, the protein stretches without breaking and molds well to any object it coats, even metal tubes 1.5 mm in diameter and 12 mm in length. Most importantly, the body won’t reject it. Gregory and his team at OMLC completed tests on domestic pigs last fall with “extremely successful” results and plan to start human trials in Brazil later this year. Once the design gets FDA approval — Gregory expects within two years — he’ll begin marketing the new device in hopes that this “metal, human-protein hybrid” will succeed where lesser stents have failed. Lives saved by listening to nature. EVAN CAEL
Thursday, July 31, 2014
BY MARY SPILDE | OB GUEST CONTRIBUTOR
Faced with the aftermath of the “great recession,” increasing concern about the environment and dwindling family wage jobs, we have some very important choices to make about our future.
Wednesday, August 13, 2014
BY TOM COX | OB BLOGGER
When I say, “Your Employee is Always Right,” I do not mean “right about the facts,” but rather “right about how they feel” and “right about how they want to be led.”
Friday, August 15, 2014
In this week's poll, we asked readers: "Who should pay for the troubled Cover Oregon website?" Here are the results.
Wednesday, August 27, 2014
Tom Cox interviews Pete Friedes, author of "The 2R Manager," about becoming a Best Boss.
Monday, August 18, 2014
Portland is in the middle of another construction boom, with residential and office projects springing up downtown, in the Pearl and Old Town. OB Web Editor Jessica Ridgway documents the new wave.
Monday, August 25, 2014
BY JASON NORRIS | OB GUEST BLOGGER
Ferguson Wellman’s investment views on the economy and capital markets.
Tuesday, August 19, 2014
BY TOM COX | OB BLOGGER
Tom Cox interviews Steve Balzac, author of "Organizational Psychology for Managers."
|The Private 150: Bigger But Leaner|
|The Perfect Food|
|Powerlist: Staffing Firms|
|Taxis Uber Alles?|
|Google tests drone deliveries|
|Abercrombie to remove logos from most clothing|
|FBI investigates JPMorgan 'cyber-attack'|
|GoPro launches camera dog harnesses|
|Snapchat now worth $10B|
|Tomatoes may lower prostate cancer risk|
|WHO: Ban e-cigarette use indoors|
Vigilant enters a New Year with a new president.
How George Fox has become one of Oregon's largest private universities.
Forest Grove sees growth in the burgeoning food and beverage scene.
Lane Powell Shareholder William T. Patton has been appointed to the board of directors for Cascade AIDS Project, an organization that provides educational services and outreach to thousands of Oregonians living with HIV/AIDS.
Fifty-one Lane Powell lawyers were recently selected by their peers for inclusion in The Best Lawyers in America® (Best Lawyers) 2015; of those selected, 23 lawyers are from the Firm’s office in Portland, Oregon.
Barran Liebman is proud to announce that Andrew Schpak, a Partner of the firm, has been named Chair of the American Bar Association’s Young Lawyers Division for the 2014-2015 bar year.